ChinaTechSignals

Database

Funding Rounds

352 rounds tracked

$29MSeries A
Yaoshu Technologyaibiotech
15 Apr 2024

Yaoshu Technology is an AI for 3D Biology platform company that integrates organ-on-chip technology with AI models to support drug development and personalized medicine, enabling toxicity assessment and individualized therapeutic applications.

China Life Insurance Equity Investment, XtalPi, Yaye Capital

Source →
$22MSeries A
Xiangke Intelligenceroboticsai
15 Apr 2024

A robotics company specializing in embodied AI and large language model-driven robot technology for kitchen applications, with expansion into broader smart space services in restaurants and hotels.

Ninebot, Changsha Dongfang Private Fund, Jiangsu Guosheng Capital

Source →
$15MPre-A
Yuansheng Intelligentairobotics
15 Apr 2024

A robotics company that develops high-performance dexterous hands (robotic grippers) with advanced tactile sensing capabilities. Their flagship product Apex Hand is designed for precise manipulation tasks across industrial and research applications.

Dachen Financial Intelligence, Chunhua Innovation Fund, Shance Capital, Nanshan Strategic New Investment

Source →
UndisclosedSeries C
OSChinaaisaas
14 Apr 2024

OSChina is a domestic core open-source and AI infrastructure service provider, operating the professional open-source technology community OSCHINA.NET and the global second-largest code hosting platform Gitee, serving key sectors like finance, military, and state-owned enterprises with digital transformation solutions.

Shanghai State Investment Leading Fund, Suzhou Innovation Investment

Source →
UndisclosedSeries C
Landdot Touch Controlroboticshardware
14 Apr 2024

A leading provider of six-axis force sensors and force control sensing technology for intelligent robots, specializing in high-precision force perception components for humanoid robots and robotic applications.

Intelligent Robot, Galaxy Universal

Source →
$585KSeed
ReHealth AIaihealthtech
13 Apr 2024

A preventive healthcare AI company that builds a unified platform for cardiovascular risk prediction, personalized intervention generation, causal inference analysis, and settlement evidence generation to help insurers and healthcare institutions identify and manage high-risk patients.

undisclosed

Source →
$200MSeries B
Zhongqing Roboticsrobotics
10 Apr 2024

A robotics company founded in 2023 that develops, manufactures, and commercializes humanoid robots and related products for research, industrial, commercial, and home applications.

Zhongchuang Zhiling, Longgang Jingkong +more

Source →
$88MSeries E+
Lanxi Zhide New Energy Materials Co., Ltd.biotechenergy
9 Apr 2024

A leading enterprise focused on the research and development of silicon-carbon anode materials for lithium-ion batteries, offering high-performance products with low expansion rates and long cycle life through proprietary spherical phenolic resin mesoporous carbon and CVD technology.

Chaohui Capital, Dachen Finance and Wisdom, China Securities Investment, Junhao Capital +more

Source →
$29MSeries D+
Aimit Medicalhealthtechhardware
9 Apr 2024

Aimit Medical is a medical device company focused on vascular intervention, developing 3D-printed biodegradable vascular stents and CO2 contrast injection devices for cardiovascular, peripheral vascular, and neurovascular applications.

Zhejiang Cooperative Life Health Fund, Henan Key Intellectual Property Fund, Global Hedge Fund Management Co., Ltd.

Source →
UndisclosedSeries A
Shuangpai Roboticsroboticshealthtech
8 Apr 2024

A technology company that develops and sells age-friendly smart mobility devices including intelligent wheelchairs, mobility scooters, and smart walkers designed for elderly users.

Tiantu Capital, Guoshun Investment, West Lake Innovation Fund

Source →
UndisclosedPre-A
Coze Yongxin Biotechnologybiotech
8 Apr 2024

A high-tech company focused on research and development of oligonucleotide core backbone raw materials and products, supplying high-quality oligonucleotide precursor products for nucleic acid drug development.

Dishen Capital, Jiale Capital

Source →
UndisclosedPre-A
Unbounded Arkaihardware
2 Apr 2024

A startup developing a next-generation AIOS (AI Operating System) called EVA OS for hardware devices, featuring multimodal AI interaction capabilities with ultra-low latency and enabling natural language-based hardware application development.

AfterShokz (Shokz), Guorui Source Capital, Hengson Capital

Source →
$725KStrategic
Leeman Optoelectronic Technology Co., Ltd.aihardware
2 Apr 2024

A leading LED display technology company that develops PSE energy-saving cold screen technology to provide environmentally friendly LED display solutions for enterprises.

Yinbo Iteration Private Fund Management (Shanghai) Co., Ltd., Leeman Optoelectronic Technology Co., Ltd.

Source →
$150MSeries B
Syneron Biobiotech
31 Mar 2024

An intelligent platform-driven macrocyclic peptide drug discovery and development company. Develops innovative therapeutic candidates across oncology, autoimmune, metabolic, and rare diseases using its proprietary Synova™ platform.

International biotech fund, Dechen Capital, Temasek Tan Ming Capital, ADIA +more

Source →
$15.7BStrategic
Unileverecommerce
31 Mar 2024

Unilever is negotiating a potential merger of its food business with Mykind, a food company, combining their food operations.

UndisclosedIPO
Huayan Roboticsroboticsmanufacturing
30 Mar 2024

A collaborative robotics company specializing in self-developed core components including motors, servo drives, motion control, and joint modules for industrial automation applications.

Guangfa Fund, Morgan Stanley

Source →
$43MSeries A
MicroCytobiotechai
30 Mar 2024

MicroCyto develops AI-powered biological computing technology to enable intelligent biomanufacturing, providing digital infrastructure for molecular docking, biological materials, and industrial enzyme design.

UndisclosedSeries B
Linghou Robotroboticsai
30 Mar 2024

Linghou Robot develops core components for embodied AI and industrial automation, including vision modules and wheeled robot chassis, with proprietary visual perception and motion control technologies.

China Core Acquisition Fund, Houwei Capital, Zhiyuan Robot, Boyuan Capital +more

Source →
UndisclosedSeries B
Rhinoburn Medicalhealthtechhardware
27 Mar 2024

A domestic manufacturer of high-end ophthalmologic medical devices that develops and provides surgical equipment, consumables, and training services for ophthalmic solutions, including phacoemulsification-vitrectomy combination machines and other advanced eye surgery devices.

Yuexiu Industrial Fund, Taiyu Investment

Source →
$58MPre-IPO
Tupa Medical Technology Group Co., Ltd.healthtechhardware
26 Mar 2024

A medical device company specializing in high-end ophthalmic equipment including OCT systems, surgical microscopes, and laser-assisted cataract surgery systems, with technology originating from Tsinghua University.

Chengdu Science and Technology Innovation Investment Group, Sichuan Science and Technology Innovation Investment Group, Tsinghua Control Gold Letter Capital +more

Source →
UndisclosedSeries B
Qiangsi Digital Technologyaimanufacturing
24 Mar 2024

Qiangsi Digital Technology develops spatial AI and industrial software solutions for 3D reconstruction and digital modeling of industrial facilities, enabling high-precision industrial world models and autonomous operations in complex manufacturing environments.

Lanpu Capital, Enxi Investment

Source →
UndisclosedSeries A
Jingxiang Technologyaihealthtech
24 Mar 2024

Jingxiang Technology develops M1, a vertical emotional psychology large language model focused on AI emotional companionship with emphasis on professional expertise, empathy, and safety. The technology is designed for both medical-grade scenarios and consumer-level applications.

Kepu Biology

Source →
UndisclosedAngel
Fungifuturebiotechmanufacturing
23 Mar 2024

A synthetic biology new materials company focused on mycelium fiber material research and production, utilizing fermentation technology to create bio-based materials for packaging, construction, and fashion applications.

UndisclosedAngel
Maibozhi Starbiotech
23 Mar 2024

A biotech company focused on innovative antibody drug development for treating inflammatory and autoimmune diseases, with operations in Beijing, China and Cambridge, UK.

Longpan Investment, Chaosheng Capital, Yijing Capital

Source →